—Even long after the active phase of thyroid eye disease has subsided, a multitude of challenging quality-of-life issues may persist. Several recent studies have established that the physical ...

LOS ANGELES, CA, UNITED STATES, January 22, 2026 / EINPresswire.com / — Renowned physician Dr. Raymond Douglas will be featured in an upcoming local segment of The Balancing Act ®, a nationally ...

Fibroblasts from patients with TED secrete active PAPP-A and are stimulated by proinflammatory cytokines, namely tumor necrosis factor (TNF)-α and interleukin (IL)-1β. Novel therapeutic agents may be ...

As mentioned in Overview, most thyroid eye disease (TED) cases are closely related to hyperthyroidism. Approximately 85% of patients with TED develop the disease around 18 months before or after the ...

The global thyroid eye disease (TED) market is experiencing growth due to innovative treatment options, enhanced diagnostics, and increased awareness. TED, linked to hyperthyroidism, causes eye ...

Please provide your email address to receive an email when new articles are posted on . Thyroid eye disease treatments have evolved significantly in recent years. Work is still needed to find durable, ...

(Reuters) -Viridian Therapeutics said on Tuesday its experimental treatment helped significantly reduce symptoms of thyroid eye disease (TED) in a late-stage study, setting the stage to become the ...

Ever felt mild irritation, redness, and tearing in the eyes and thought something must have gotten stuck? While it may be a temporary issue or a serious condition like Thyroid Eye Disease (TED), an ...

BOSTON—Most patients with thyroid eye disease treated with teprotumumab didn’t require additional treatments nearly 2 years later, according to industry-supported research being presented Sunday at ...

Nearly 2 years after their final infusion with the IGF-IR inhibitor teprotumumab (Tepezza), 82% of patients with thyroid eye disease did not need further treatment for their symptoms, revealed ...

Untreated thyroid disorders in pregnancy can affect a baby's brain, growth and vision. Experts explain why early screening and treatment are critical for long-term child development.